跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED WAVERLEY 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PEMETREXED WAVERLEY 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
PEMETREXED WAVERLEY 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Waverley Pharma Europe Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 6, 2020
Approval ID
3d740fe734d17277
Company
Waverley Pharma Europe Limited
Type
Standard
Approval Details
Approval Id
3d740fe734d17277
Drug Cima Aemps Name
PEMETREXED WAVERLEY 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
85014
Holder Company Name
Waverley Pharma Europe Limited
Marketing Company Name
Viso Farmaceutica S.L.U.
Authorization Date
2020-08-06
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
500 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Waverley Pharma Europe Limited
Active Ingredients
PEMETREXED
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 6, 2020
Approval ID
3d740fe734d17277
Type
Standard
Back to CIMA-AEMPS Approvals